Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 501–600 of 1,009
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 81
“Supporting this hypothesis, oncogene-induced senescence following aberrant RAS activation led to the arrest of premalignant cells and secretion of proinflammatory SASP factors that promoted innate and adaptive immunity cell clearance of incipient cancer cells and blocked tumor formation [35].”
BackgroundStress-induced β cell early senescence confers protection against type 1 diabetes
Lee, H., Sahin, G. S., Chen, C.-W., Sonthalia, S., Cañas, S. M., Oktay, H. Z., Duckworth, A. T., Brawerman, G. M., Thompson, P. J., Hatzoglou, M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.014 · Cited by 70
Chemotherapy awakens dormant cancer cells in lung by inducing neutrophil extracellular traps
He, D., Wu, Q., Tian, P., Liu, Y., Jia, Z., Li, Z., Wang, Y., Jin, Y., Luo, W., Li, L., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.007 · Cited by 80
Burton, D. G. A., Giribaldi, M. G., Muñoz, A., Halvorsen, K. T., Patel, A., Jordà, M., Perez‐Stable, C., & Rai, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068003 · Cited by 73
Emerging roles of lnc RNA s in senescence
Montes, M., & Lund, A. H. (2016) · FEBS Journal · doi:10.1111/febs.13679 · Cited by 69
p53’s Extended Reach: The Mutant p53 Secretome
Pavlakis, E., & Stiewe, T. (2020) · Biomolecules · doi:10.3390/biom10020307 · Cited by 68
“Similarly, pre-malignant senescent hepatocytes secrete chemo- and cytokines that trigger immune-clearance dependent on CD4+ T cells and monocytes/macrophages [74].”
BackgroundSenescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 70
Senolytic treatment rescues blunted muscle hypertrophy in old mice
Dungan, C. M., Figueiredo, V. C., Wen, Y., VonLehmden, G. L., Zdunek, C. J., Thomas, N. T., Mobley, C. B., Murach, K. A., Brightwell, C. R., Long, D. E., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00542-2 · Cited by 65
Telomeres, cellular senescence, and aging: past and future
Eppard, M., Passos, J. F., & Victorelli, S. G. (2023) · Biogerontology · doi:10.1007/s10522-023-10085-4 · Cited by 71
“The SASP is thought to be a mechanism by which senescent cells communicate with the immune system (likely to orchestrate their own clearance) (Kang et al. 2011).”
Wang, Z., Yan, J., Lin, H., Hua, F., Wang, X., Liu, H., Lv, X., Yu, J., Mi, S., Wang, J., et al. (2013) · Hepatology · doi:10.1002/hep.26234 · Cited by 65
“However, if HCC is primarily caused by chemical agents or metabolic stresses, the residue liver cells undergoing premature senescence are predominant party to initiate and sustain inflammation participating in the regulation of HCC development.(5) Obviously, the immunity against tumorigenesis is constituted by both li…”
BackgroundThe senescent hepatocyte gene signature in chronic liver disease
Aravinthan, A., Shannon, N., Heaney, J., Hoare, M., Marshall, A., & Alexander, G. J. M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.011 · Cited by 65
Cellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
Docherty, M. H., Baird, D., Hughes, J., & Ferenbach, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00755 · Cited by 69
Elsayed, R., Elashiry, M., Liu, Y., El-Awady, A., Hamrick, M., & Cutler, C. W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.669989 · Cited by 64
“…cells, but can also occur in terminally differentiated cells (Herranz and Gil, 2018; Sapieha and Mallette, 2018; Wengerodt et al., 2019) such as neurons (Jurk et al., 2012), hepatocytes (Kang et al., 2011), osteocytes (Aquino-Martinez et al., 2020), and macrophages (Hall et al., 2016).”
BackgroundLXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer
Rudalska, R., Harbig, J., Snaebjornsson, M. T., Klotz, S., Zwirner, S., Taranets, L., Heinzmann, F., Kronenberger, T., Förster, M., Cui, W., et al. (2021) · Nature Cancer · doi:10.1038/s43018-020-00168-3 · Cited by 67
Self-citationSenescent T cells: Beneficial and detrimental roles
Laphanuwat, P., Gomes, D. C. O., & Akbar, A. N. (2023) · Immunological Reviews · doi:10.1111/imr.13206 · Cited by 67
COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells
McHugh, D., Sun, B., Gutierrez-Muñoz, C., Hernández-González, F., Mellone, M., Guiho, R., Duran, I., Pombo, J., Pietrocola, F., Birch, J., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01287-6 · Cited by 59
“Next, we employed a model of liver tumour initiation in which senescence is induced in hepatocytes by transposon-mediated transfer of oncogenic NRAS (NRAS G12V ) 55 .”
MethodSelf-citationCellular senescence: mechanisms and relevance to cancer and aging
Yamauchi, S., & Takahashi, A. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae079 · Cited by 69
“2) (23) .”
FBP1 controls liver cancer evolution from senescent MASH hepatocytes
Gu, L., Zhu, Y., Nandi, S. P., Lee, M., Watari, K., Bareng, B., Ohira, M., Liu, Y., Sakane, S., Carlessi, R., et al. (2025) · Nature · doi:10.1038/s41586-024-08317-9 · Cited by 74
Induction of Fibroblast Senescence During Mouse Corneal Wound Healing
Wang, X., Qu, M., Li, J., Danielson, P., Yang, L., & Zhou, Q. (2019) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.19-26983 · Cited by 58
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60
“And while the previous study (46) reported senescent cell clearance dependent solely on innate immunity, this later study indicated that not only were both arms of the immune system required for senescence surveillance, but also that antigen specificity played a role (5).”
InfluentialCellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
Innate immunosensing of DNA in cellular senescence
Glück, S., & Ablasser, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.013 · Cited by 66
The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
Engelmann, C., & Tacke, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020652 · Cited by 61
“In the context of mutations, senescence is considered protective since it prevents the unlimited proliferation and dissemination of potentially malignant cells [23].”
BackgroundSelf-citationMetabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Leslie, J., Geh, D., Elsharkawy, A. M., Mann, D. A., & Vacca, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.029 · Cited by 61
The therapeutic landscape of hepatocellular carcinoma
Gallage, S., Beccaria, M. G., Szydlowska, M., Rahbari, M., Mohr, R. U., Tacke, F., & Heikenwälder, M. F. (2021) · Med · doi:10.1016/j.medj.2021.03.002 · Cited by 64
Self-citationPancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight
Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 65
“On one hand, it may promote an immunosuppressive environment, while on the other hand, it may activate the so-called senescence surveillance, which is able to remove senescent cells [180].”
BackgroundLu, W.-J., Chua, M., & So, S. K. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt401 · Cited by 62
Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
Walton, C. C., Begelman, D., Nguyen, W., & Andersen, J. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00129 · Cited by 62
Cellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Brown, G., Vilalta, A., & Fricker, M. (2015) · Current Molecular Medicine · doi:10.2174/156652401509151105130628 · Cited by 57
“Phagocytosis of live cancer cells may result from the exposure of novel antigens, phosphatidylserine [54], senescence markers [40] or calreticulin [70].”
BackgroundBing, X., Yamamoto, M., Fujii, K., Ooshio, T., Chen, X., Okada, Y., Watanabe, K., Miyokawa, N., Furukawa, H., & Nishikawa, Y. (2017) · Oncogene · doi:10.1038/onc.2017.114 · Cited by 65
Radiotherapy-Induced Senescence and its Effects on Responses to Treatment
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D., & Macip, S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.003 · Cited by 63
Filliol, A., & Schwabe, R. F. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685539 · Cited by 58
Senescence under appraisal: hopes and challenges revisited
Davan-Wetton, C. S. A., Pessolano, E., Perretti, M., & Montero‐Melendez, T. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03746-x · Cited by 64
“In addition, it was found that monocytes/macrophages were required to complete the clearance of senescent hepatocytes after CD4+ T cells activity [86].”
BackgroundImmune Surveillance of Unhealthy Cells by Natural Killer Cells
Iannello, A., & Raulet, D. H. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020255 · Cited by 54
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
Reimann, M., Schrezenmeier, J., Richter-Pechanska, P., Dolnik, A., Hick, T. P., Schleich, K., Cai, X., Fan, D. N. Y., Lohneis, P., Maßwig, S., et al. (2021) · Blood · doi:10.1182/blood.2020005244 · Cited by 59
MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells
Potter, M. L., Hill, W., Isales, C. M., Hamrick, M. W., & Fulzele, S. (2020) · Bone · doi:10.1016/j.bone.2020.115679 · Cited by 63
Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
Aquino-Martínez, R., Khosla, S., Farr, J. N., & Monroe, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207441 · Cited by 67
“This process is called senescent cell immune surveillance, in which the release of senescence-associated proinflammatory signals play essential roles in attracting neutrophils, macrophages, lymphocytes and natural killer cells [67,83,85].”
BackgroundDiverse roles of hepatitis B virus in liver cancer
Fallot, G., Neuveut, C., & Buendia, M. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.05.008 · Cited by 66
p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions
Fujita, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236023 · Cited by 56
Lipid Players of Cellular Senescence
Millner, A., & Atilla-Gokcumen, G. E. (2020) · Metabolites · doi:10.3390/metabo10090339 · Cited by 55
“The released SASP components exert their tumor-suppressive effects by recruiting different types of immune cells to the tumor environment, resulting in the elimination of senescent and damaged cells [53,54].”
BackgroundIltis, C., Moskalevska, I., Debiesse, A., Seguin, L., Fissoun, C., Cervera, L., Moudombi, L., Ardin, M., Ferrari, A., Eliott, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00776-z · Cited by 59
Moreira, P., Sousa, F. J., Matos, P., Brites, G. S., Gonçalves, M. J., Cavaleiro, C., Figueirinha, A., Salgueiro, L., Batista, M. T., Branco, P. C., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030561 · Cited by 62
“Indeed, it has been demonstrated that immune cells are able to identify and eliminate senescent cells [80,81].”
BackgroundXiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 66
“15 Additionally, in HrasG12V-mutated hepatocellular carcinoma (HCC), senescent HCC cells secrete SASP factors (such as CCL2, IL-15 and CXCL1) that activate macrophages, neutrophils and NK cells, thereby mediating innate immunity and suppressing tumour progression.”
BackgroundA Crucial Role for CDC42 in Senescence-Associated Inflammation and Atherosclerosis
Ito, T. K., Yokoyama, M., Yoshida, Y., Nojima, A., Kassai, H., Oishi, K., Okada, S., Kinoshita, D., Kobayashi, Y., Fruttiger, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102186 · Cited by 57
Dynamic plasticity of macrophage functions in diseased liver
Ritz, T., Krenkel, O., & Tacke, F. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.007 · Cited by 58
Self-citationPeña‐Asensio, J., Sánchez, H. C., Torralba, M., Miquel, J., Sanz‐de‐Villalobos, E., & Larrubia, J. R. (2021) · Cancers · doi:10.3390/cancers13081922 · Cited by 63
“Therefore, large numbers of CD8+ TILs in HCC correlate with improved OS, longer relapse-free survival, and diminished disease progression [10,45,46].”
BackgroundCellular senescence: a double‐edged sword in the fight against cancer
Ohtani, N., Takahashi, A., Mann, D. J., & Hara, E. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01493.x · Cited by 57
Tanaka, Y., & Takahashi, A. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa109 · Cited by 64
Escape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 63
Calabrò, A., Accardi, G., Aiello, A., Caruso, C., Galimberti, D., & Candore, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031792 · Cited by 53
Immunosurveillance as a regulator of tissue homeostasis
Senovilla, L., Galluzzi, L., Zitvogel, L., & Kroemer, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.005 · Cited by 62
NF1 loss induces senescence during human melanocyte differentiation in an iPSC‐based model
Larribere, L., Wu, H., Novak, D., Galach, M., Bernhardt, M., Orouji, E., Weina, K., Knappe, N., Sachpekidis, C., Umansky, L., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12369 · Cited by 54
“…established as safeguard programs against cancer in benign lesions such as melanocytic nevi, premalignant hepatocytes, astrocytomas, prelymphomagenic thymocytes, and benign neurofibromas (Courtois-Cox et al., 2006; Hanna et al., 2010; Kang et al., 2011; Michaloglou et al., 2005; Xu et al., 2008).”
BackgroundThrombospondin-1 mediates oncogenic Ras–induced senescence in premalignant lung tumors
Baek, K.-H., Bhang, D., Zaslavsky, A., Wang, L.-C., Vachani, A., Kim, C. F., Albelda, S. M., Evan, G. I., & Ryeom, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67465 · Cited by 57
“cent cells by infiltrating immune cells (17).”
Estevez, J., Chen, V. L., Podlaha, O., Li, B., Le, A. K., Vutien, P., Chang, E. T., Rosenberg‐Hasson, Y., Jiang, Z., Pflanz, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11975-7 · Cited by 59
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症:英文版 · doi:10.1002/cac2.12182 · Cited by 64
“The SASP is involved in recruiting immune cells to clear aging cells,which allows the SASP to recruit Th1 cells, NK cells, and macrophages to eliminate incipient tumor cells [288].”
BackgroundSWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer
Tordella, L., Khan, S., Hohmeyer, A., Banito, A., Klotz, S., Raguz, S., Martin, N., Dhamarlingam, G., Carroll, T., González Meljem, J. M., et al. (2016) · Genes & Development · doi:10.1101/gad.286112.116 · Cited by 58
“Mutations in its paralog ARID1B are less frequent but have also been observed in melanoma, gastric, colorectal, HCC, neuroblastoma and pancreatic cancer (Fujimoto et al. 2012; Khursheed et al. 2013; Sausen et al. 2013; Lee et al. 2015).”
BackgroundSelf-citationMacrophages as key regulators of liver health and disease
Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 71
Enhanced killing of therapy‐induced senescent tumor cells by oncolytic measles vaccine viruses
Weiland, T., Lampe, J., Essmann, F., Venturelli, S., Berger, A., Bossow, S., Berchtold, S., Schulze‐Osthoff, K., Lauer, U. M., & Bitzer, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28350 · Cited by 55
“For HCC, it had been shown that the development of cancer could be associated with an escape from a senescence arrest of premalignant hepatocytes, which clearly emphasizes the importance of senescence surveillance in vivo.(33) Thus, for combinatorial treatment approaches exploiting the capacity of tumor cells to under…”
BackgroundSenescence and tumor suppression
Hinds, P., & Pietruska, J. (2017) · F1000Research · doi:10.12688/f1000research.11671.1 · Cited by 57
Leibold, J., Ruscetti, M. A., Cao, Z., Ho, Y.-J., Baslan, T., Zou, M., Abida, W. M., Feucht, J., Han, T., Barriga, F. M., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1242 · Cited by 58
“Other nongermline mouse modeling approaches, for example, organoid transplantation (40, 43, 44), stem cell manipulation/retransplantation (45, 46), and other somatic tissue engineering approaches (47, 48), are continuing to make mouse models more accessible to the broader research community.”
BackgroundTranslational Control during Cellular Senescence
Payea, M. J., Anerillas, C., Tharakan, R., & Gorospe, M. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00512-20 · Cited by 54
Helbling-Leclerc, A., Garcin, C., & Rosselli, F. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00764-5 · Cited by 61
“Finally, premalignant senescent cells are removed from healthy tissue by an efficient immune-surveillance system that entails both the innate and adaptive immune response through the “senescence surveillance” pathway [28].”
BackgroundCellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 58
Wong, A. M., Ding, X., Wong, A. M. G., Xu, M., Zhang, L., Leung, H. H. W., Chan, A. W. H., Song, Q. X., Kwong, J., Chan, L. K., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.015 · Cited by 64
HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation
Efimova, E. V., Ricco, N., Labay, E., Mauceri, H. J., Flor, A. C., Ramamurthy, A., Sutton, H. G., Weichselbaum, R. R., & Kron, S. J. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0288 · Cited by 52
“While considerable disagreement remains whether TIS is a desirable or detrimental outcome of treatment (6–10), several studies indicate that senescent cells can suppress proliferation of surviving tumor cells and/or promote antitumor immune response (5, 11, 12).”
BackgroundL’Hermitte, A., Pham, S., Cadoux, M., Couchy, G., Caruso, S., Anson, M., Crain‐Denoyelle, A., Celton‐Morizur, S., Yamagoe, S., Zucman‐Rossi, J., et al. (2018) · Hepatology · doi:10.1002/hep.30140 · Cited by 58
“In several murine models of HCC, both innate and adaptive immune system components have been shown to participate in tumor development and progression, highlighting the intricate nature of the crosstalk between the immune system and tumor cells.(13-15) Approaches targeting TME composition are therefore considered an e…”
BackgroundOhtani, N. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz055 · Cited by 57
Aging and Options to Halt Declining Immunity to Virus Infections
Palacios-Pedrero, M. Á., Osterhaus, A. D. M. E., Becker, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681449 · Cited by 61
Restored immune cell functions upon clearance of senescence in the irradiated splenic environment
Palacio, L., Goyer, M., Maggiorani, D., Espinosa, A., Villeneuve, N., Bourbonnais, S., Moquin‐Beaudry, G., Le, O., Demaria, M., Davalos, A. R., et al. (2019) · Aging Cell · doi:10.1111/acel.12971 · Cited by 54
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L., Simonnet, H., & Bernard, D. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.63 · Cited by 52
Li, Z.-Y., Chen, Z., Zhang, T., Wei, C., & Shi, W. (2016) · Aging · doi:10.18632/aging.101050 · Cited by 60
“Moreover, through the acquisition of a senescence-associated secretory phenotype (SASP), senescent cells can reinforce senescence and activate immune surveillance, and paradoxically have protumorigenic properties [10-12].”
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
Tang, M., Zhao, Y., Zhao, J., Wei, S., Liu, M., Zheng, N., Geng, D., Han, S., Zhang, Y., Zhong, G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn5683 · Cited by 61
“Thus, divergent phenotypes may be caused by RAS-induced premalignant senescence program and differential cell death–related microenvironment ( 43 , 44 ).”
Gungor, M. Z., Uysal, M., & Şentürk, Ş. (2022) · Cancers · doi:10.3390/cancers14040940 · Cited by 58
“Yet, other observations with a murine model of intrahepatic Ras expression found that the immune-mediated clearance of premalignant senescent hepatocytes could suppress liver cancer development [88].”
BackgroundNelson, D. M., McBryan, T., Jeyapalan, J. C., Sedivy, J. M., & Adams, P. D. (2014) · AGE · doi:10.1007/s11357-014-9637-0 · Cited by 64
“The proliferation arrest restrains tumor growth, and the SASP recruits innate immune cells to clear the damaged premalignant cells (Xue et al. 2007; Kang et al. 2011).”
BackgroundSadaie, M., Dillon, C., Narita, M., Young, A. R. J., Cairney, C. J., Godwin, L. S., Torrance, C. J., Bennett, D. C., Keith, W. N., & Narita, M. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-01-0003 · Cited by 57
“These synchronized cells were washed three times with 200 μl of prewarmed PBS may recur (Kang et al., 2011).”
BackgroundInfluentialCellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Yasuda, T., Baba, H., & Ishimoto, T. (2021) · FEBS Journal · doi:10.1111/febs.16231 · Cited by 61
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 71
“…remains to be elucidated, because different studies have found that inhibition of mTOR, which is known to activate autophagy, alternately delays or potentiates aspects of senescence (Cao et al., 2011; Demidenko et al., 2009; Iglesias-Bartolome et al., 2012; Kennedy et al., 2011; Wall et al., 2013).”
BackgroundFerrand, M., Kirsh, O., Griveau, A., Vindrieux, D., Martin, N., Defossez, P.-A., & Bernard, D. (2015) · Aging · doi:10.18632/aging.100845 · Cited by 50
Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria
Fan, Y., Cheng, J., Zeng, H., & Shao, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.593630 · Cited by 51
Senescent cells in cancer therapy: why and how to remove them
Zhang, J., Zhang, D., & Yu, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.002 · Cited by 59
Liu, Y., Pagacz, J., Wolfgeher, D. J., Bromerg, K. D., Gorman, J. V., & Kron, S. J. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005862 · Cited by 54
Du, M., Sun, L., Guo, J. J., & Lv, H. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107198 · Cited by 57
Systemic DNA damage responses: organismal adaptations to genome instability
Ermolaeva, M. A., & Schumacher, B. (2014) · Trends in Genetics · doi:10.1016/j.tig.2013.12.001 · Cited by 50
“In contrast, the senescence program can also suppress tumorigenesis; for instance pre-malignant senescent cells activate adaptive immune responses to ignite tumor surveillance [37].”
BackgroundWang, P., Han, L., Shen, H., Wang, P., Lv, C., Zhao, G., Niu, J., Xue, L., Wang, Q. J., Tong, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310972111 · Cited by 49
“SASP factors also can stimulate immune system to clear premalignant senescent cells through so called “senescence surveillance” mechanism (13).”
BackgroundGoh, J., & Ladiges, W. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.06.004 · Cited by 56
YAP determines the cell fate of injured mouse hepatocytes in vivo
Miyamura, N., Hata, S., Itoh, T., Tanaka, M., Nishio, M., Itoh, M., Ogawa, Y., Terai, S., Sakaida, I., Suzuki, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms16017 · Cited by 51
Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50
Brauer, E., Lange, T., Keller, D., Görlitz, S., Cho, S., Keye, J., Gossen, M., Petersen, A., & Kornak, U. (2022) · Aging Cell · doi:10.1111/acel.13744 · Cited by 55
“Senescent cells secrete a variety of pro- inflammatory cytokines as part of the senescence- associated secretory phenotype (SASP) (Coppé et al., 2010) that lead to the recruitment of the immune system and subsequent cell clearance (Hoenicke & Zender, 2012; Kang et al., 2011).”
BackgroundThe paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 62
“TheSASPhasbeenimplicatedameansof senescentcellclearance,withfactorssuchasIL-8facilitatingtherecruitment ofinnateimmunecellsincludingNKcells,macrophages,and neutrophils 90,91 .”
Immune surveillance of senescent cells in aging and disease
Majewska, J., & Krizhanovsky, V. (2025) · Nature Aging · doi:10.1038/s43587-025-00910-5 · Cited by 58
“CD4 + T cells have a central role in immune-mediated clearance of prema-lignant oncogene-induced senescent hepatocytes, thereby preventing tumor development 48 .”
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
“Acting as a cell cycle break, OIS removes the dividing cells from the proliferative pool, thereby crafting a crucial pathophysiological barrier to prevent tumorigenesis.(24,57) Recent studies have shown that OIS is also mediated by a DDR.”
BackgroundTunçbilek, M., Güven, E. B., Onder, T., & Çetin-Atalay, R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3001532 · Cited by 50
Aspirin Targets SIRT1 and AMPK to Induce Senescence of Colorectal Carcinoma Cells
Jung, Y. R., Kim, E. J., Choi, H. J., Park, J.-J., Kim, H.-S., Lee, Y., Park, M., & Lee, M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098616 · Cited by 51
“On the other hand, the components of the senescenceassociated secretory phenotype have anticancer functions that contribute to the removal of tumor cells by the immune system (Kang et al., 2011; Sagiv and Krizhanovsky, 2013).”
BackgroundEmerging Role of the Unfolded Protein Response in Tumor Immunosurveillance
Vanacker, H., Vetters, J., Moudombi, L., Caux, C., Janssens, S., & Michallet, M. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.05.005 · Cited by 53
“The composition of the SASP may vary according to the cell type or the oncogene, shaping an either immunogenic [52,53] or tolerogenic [54] effect on immune cells.”
Reactive Oxygen Species Detection in Senescent Cells
Victorelli, S. G., & Passos, J. F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_3 · Cited by 55
Wang, K., Shang, F., Chen, D., Cao, T., Wang, X., Jiao, J., He, S., & Liang, X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00777-9 · Cited by 49
“Liver cancer is a kind of common malignant tumor with poor prognosis [1-3].”
BackgroundSharma, R. (2021) · Biogerontology · doi:10.1007/s10522-021-09936-9 · Cited by 55
Macrophage Involvement in Aging-Associated Skeletal Muscle Regeneration
Cui, C., Ferrucci, L., & Gorospe, M. (2023) · Cells · doi:10.3390/cells12091214 · Cited by 53
“Macrophages remove senescent cells by phagocytosis [149–151].”
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.